Streetbeat News

Products Services

NVO

Novo Nordisk has decided to halt its kidney outcomes trial FLOW based on the recommendation from an independent data monitoring committee. The decision was made after interim analysis met certain pre-specified criteria for stopping the trial early due to efficacy.

Portfolio Pulse from Bill Haddad

October 10, 2023 | 8:42 pm

CI

Evernorth Health Services, a division of The Cigna Group (NYSE:CI), is set to enhance MDLIVE's virtual care by acquiring the technology and clinical capabilities of Bright.md. The acquisition will add asynchronous care, triage, and navigation capabilities to MDLIVE's virtual care platform, aiming to improve patient access to high-quality care and reduce the total cost of care. The new features will be available for patients and clinicians beginning in 2024. Additionally, MDLIVE is expanding its virtual primary care service to include health coaching for patients with chronic conditions.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:38 pm

HEPS

V

Visa (NYSE:V) has entered into a five-year partnership with Turkish e-commerce platform Hepsiburada (NASDAQ:HEPS) to ensure the acceptance of Hepsipay's digital prepaid cards worldwide. The cards, which will bear the Visa logo, can be created easily and topped up through various methods. Hepsipay is the first platform wallet licensed by the Central Bank of the Republic of Turkey.

Portfolio Pulse from Khyathi Dalal

October 10, 2023 | 8:37 pm

TPST

Tempest Therapeutics announced plans to report new and updated data from the global randomized combination study of TPST-1120 in first-line hepatocellular carcinoma. The announcement is expected to be made in a premarket press release on Wednesday, October 11th.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:35 pm

AIP

Arteris Interconnect IP has been deployed in NeuReality's inference server for generative AI and large language model applications. The technology will enhance the server's performance and efficiency.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:32 pm

CPIX

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) has announced a new publication detailing the results of the first clinical study investigating the safety and pharmacokinetics of Vibativ® (telavancin) injection in children aged 2 to 17. The study found that a single 10 mg/kg dose of Vibativ was safe with no serious adverse events or renal concerns. Vibativ is an intravenous antibiotic approved by the FDA for the treatment of certain bacterial infections in adults.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:23 pm

VKTX

Viking Therapeutics, Inc. (NASDAQ:VKTX) announced that data from the Phase 1 clinical trial of VK2735, a dual GLP-1/GIP receptor agonist, will be presented at ObesityWeek 2023. The presentation will highlight VK2735's safety, tolerability, and pharmacodynamic effects in healthy volunteers. New findings related to the impact of VK2735 on liver fat content and plasma lipid levels will also be reported.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:20 pm

TNET

TriNet has announced a collaboration with Healthee to introduce a new personalized benefits experience. The partnership aims to provide a comprehensive health and benefits solution that is personalized to meet the needs of each individual employee.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:18 pm

HYLN

Hyliion is planning a strategic review of alternatives for its electric powertrain business as it navigates the changing landscape in commercial vehicle electrification.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:18 pm

LSCC

Lattice Semiconductor's FPGAs have been selected to enable advanced driver experiences on Mazda's new CX-60 and CX-90 models. The Mazda SUVs will use a solution based on multiple low power Lattice FPGAs to provide safety-critical Advanced Driver Assistance System (ADAS) side radar applications made by Furukawa Electric. The partnership aims to enhance vehicle capabilities with advanced and reliable ADAS features.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 8:13 pm